AHA Recommends Safegaurds for AI-Enabled Medical Tools

The American Hospital Association (AHA) is calling on the Food and Drug Administration (FDA) to develop evaluation standards and measurements to assess the impacts of medical tools that use artificial intelligence. 

On Monday, AHA Senior Vice President for Public Policy Analysis and Development Ashley Thompson responded to a request from the FDA for an evaluation of AI-enabled medical devices. In the recommendation letter, she said the AHA supports AI policy frameworks that “balance flexibility to drive market-based innovations with appropriate safeguards to protect privacy and patient safety.”  

Read More

Discussion